論文 - 藤原 一男
-
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
Akaishi T、Takahashi T, Misu T, Abe M, Ishii T, Fujimori J, Aoki M, Fujihara K, Nakashima I.
Sci Rep 17 ( 10(1) ) 13890 2020年8月
-
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.
Fujihara K, Bennett JL, de Seze J, Haramura M, Kleiter I, Weinshenker BG, Kang D; Mughal T, Yamamura T.
Neurol Neuroimmunol Neuroinflamm 20 ( 7(5) ) e841 2020年8月
-
Measurements of corpus callosum index and fractional anisotropy of the corpus callosum with their cutoffs are useful to comprehend global brain volume loss in multiple sclerosis.
Fujimori J, MD, Uryu K, Fujihara K, Wattjes MP, Suzuki C, Nakashima I.
Mult Scler Relat Disord 8 ( 45 ) 102388 2020年7月
-
Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis.
Akaishi T, Takahashi T, Fujihara K, Misu T, Nishiyama S, Takai Y, Fujimori J, Abe M, Ishii T, Aoki M, Nakashima I.
Mult Scler Relat Disord 7 ( 45 ) 102382 2020年7月
-
Risk factors of attacks in neuromyelitis optica spectrum disorders.
Akaishi T, Takahashi T, Fujihara K, Misu T, Abe M, Ishii T, Aoki M, Nakashima I.
J Neuroimmunol 15 ( 343 ) 577236 2020年6月
-
Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.
Whittam DH, Cobo-Calvo A, Chiriboga ASL, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin R, Mathey G, Laplaud D, Thouvenot F, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett J, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Anu Jacob A.
Mult Scler Relat Disord 2 ( 44 ) 102251 2020年6月
-
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Fujihara K. Cook L.
Curr Opin Neurol 33 ( 3 ) 300 - 308 2020年6月
-
Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide.
Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, Jacob A, Marignier R, Weinshenker BG, Paul F, Pittock SJ, Palace J, Wingerchuk DM, Behne JM, Yeaman MR, Fujihara K, with the Guthy-Jackson Charitable Foundation International Clinical Consortium for NMOSD.
Front Neurol 26 ( 11 ) 501 2020年6月
-
Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Akaishi T, Takahashi T, Fujihara K, Abe M, Ishii T, Aoki M, Nakashima I, Misu T, Mugikura S.
PLoS One 3 ( 15(4) ) e0231225 2020年4月
-
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.
Tsymala I, Nigritinou M, Zeka B, Schulz R, Niederschick F, Matković M, Bauer IJ, Szalay M, Schanda K, Lerch M, Misu T, Fujihara K, Bennett JL, Dahle C, Pache F, Rommer P, Leutmezer F, Illes Z, Leite MI, Palace J, Scholze P, Reindl M, Lassmann H, Bradl M.
Acta Neuropathol Commun 15 ( 8(1) ) 49 2020年4月
-
Perivenous demyelination:association with anti-myelin oligodendrocyte glycoprotein.
Misu T, Takai Y, Takahashi T, Nakashima I, Fujihara K, Aoki M.
Clin Exp Neuroimmunol 11 ( Suppl. 1 ) 22 - 27 2020年
-
MOG-IgG-associated disease.
Kaneko K, Takahahi T, Misu T, Nakashima I, Fujihara K.
Clin Exp Neuroimmunol 11 ( Suppl. 1 ) 28 - 33 2020年
-
Trila of satralizumab in neuromyelitis optica spectrum disorder
Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J
N Engl J 2019年11月
-
Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy
Hino-Fukuyo N, Haginoya K, Takahashi T, Nakashima I, Fujihara K, Takai Y, Akasaka M, Kure S
Brain Dev 2019年10月
-
Neuromyelitis optica spectrum disorders: still evolving and broadening
Fujihara K
Curr Opin Neurol 2019年6月
-
Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet’s disease.
Fujimori J, Takahashi T, Matsumoto Y, Fujihara K, Takai Y, Misu T, Nakashima I
J Neuroimmunol 2019年6月
-
【補体標的治療の現状と展望】視神経脊髄炎
黒田 宙、藤原 一男
BRAIN and NERVE: 神経研究の進歩 71 ( 6 ) 573 - 580 2019年6月
-
治療法の再整理とアップデートのために 専門家による私の治療 急性散在脳脊髄炎（ADEM）
松本勇貴, 藤原一男
日本医事新報 ( 4964 ) 42 - 42 2019年6月
-
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders: tools for clinical practice and drug trial design
Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ
Brain 2019年5月
-
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.
Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, PeschL P, Bauer J, Takai T, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M.
Acta Neuropathol 137 ( 3 ) 467 - 485 2019年3月